CLC number: R743.3
On-line Access: 2024-08-27
Received: 2023-10-17
Revision Accepted: 2024-05-08
Crosschecked: 2014-02-04
Cited: 9
Clicked: 7640
Jian Shen, Yu Zhu, Hai Yu, Zuo-xu Fan, Feng Xiao, Pan Wu, Qi-hui Zhang, Xiao-xing Xiong, Jian-wei Pan, Ren-ya Zhan. Buyang Huanwu decoction increases angiopoietin-1 expression and promotes angiogenesis and functional outcome after focal cerebral ischemia[J]. Journal of Zhejiang University Science B, 2014, 15(3): 272-280.
@article{title="Buyang Huanwu decoction increases angiopoietin-1 expression and promotes angiogenesis and functional outcome after focal cerebral ischemia",
author="Jian Shen, Yu Zhu, Hai Yu, Zuo-xu Fan, Feng Xiao, Pan Wu, Qi-hui Zhang, Xiao-xing Xiong, Jian-wei Pan, Ren-ya Zhan",
journal="Journal of Zhejiang University Science B",
volume="15",
number="3",
pages="272-280",
year="2014",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B1300166"
}
%0 Journal Article
%T Buyang Huanwu decoction increases angiopoietin-1 expression and promotes angiogenesis and functional outcome after focal cerebral ischemia
%A Jian Shen
%A Yu Zhu
%A Hai Yu
%A Zuo-xu Fan
%A Feng Xiao
%A Pan Wu
%A Qi-hui Zhang
%A Xiao-xing Xiong
%A Jian-wei Pan
%A Ren-ya Zhan
%J Journal of Zhejiang University SCIENCE B
%V 15
%N 3
%P 272-280
%@ 1673-1581
%D 2014
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B1300166
TY - JOUR
T1 - Buyang Huanwu decoction increases angiopoietin-1 expression and promotes angiogenesis and functional outcome after focal cerebral ischemia
A1 - Jian Shen
A1 - Yu Zhu
A1 - Hai Yu
A1 - Zuo-xu Fan
A1 - Feng Xiao
A1 - Pan Wu
A1 - Qi-hui Zhang
A1 - Xiao-xing Xiong
A1 - Jian-wei Pan
A1 - Ren-ya Zhan
J0 - Journal of Zhejiang University Science B
VL - 15
IS - 3
SP - 272
EP - 280
%@ 1673-1581
Y1 - 2014
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B1300166
Abstract: buyang Huanwu decoction (BYHWD), a traditional Chinese herbal prescription, has been widely used clinically to treat stroke in China for hundreds of years; however, the mechanisms of this drug for stroke treatment are still unclear. This study aims to observe the cerebral angiogenesis effects of BYHWD on chronic brain injury after focal cerebral ischemia in rats and to explore its possible mechanisms. The ischemia was induced by occlusion of the right middle cerebral artery for 90 min. BYHWD (12.5 and 25.0 g/(kg∙d), equivalent to the dry weight of the raw materials) was orally administered twice a day beginning 2 h after surgery. BYHWD significantly attenuated the neurological dysfunction, infarct volume, and brain atrophy after ischemia. There was a significant increase in the microvessel density, as assessed by immunofluorescence CD31, and a significant increase in angiopoietin-1 (Ang-1) in the penumbra areas of the rats was shown by immunohistochemical staining and Western blotting. The results indicate that the neurorestorative effects of BYHWD are associated with angiogenesis and the enhancement of the expressions of Ang-1 on chronic brain injury after focal cerebral ischemia.
Open peer comments: Debate/Discuss/Question/Opinion
<1>